University of Pittsburgh researchers have developed a novel technology that enhances the potential of PROTACs (PROteolysis TArgeting Chimeras) by enabling targeted protein degradation through site-specific recruitment of ubiquitin ligase. This technology allows for the evaluation of protein degradability even in the absence of a small molecule ligand, offering an advanced novel strategy in drug discovery and precision medicine.

Shade, O., Ryan, A., Belsito, G., & Deiters, A. (2025). Investigating protein degradability through site-specific ubiquitin ligase recruitment. RSC Chemical Biology, 6(2), 240–248. https://doi.org/10.1039/d4cb00273c